1. Home
  2. WINA vs HRMY Comparison

WINA vs HRMY Comparison

Compare WINA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Winmark Corporation

WINA

Winmark Corporation

HOLD

Current Price

$426.96

Market Cap

1.5B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$39.60

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WINA
HRMY
Founded
1988
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
2.0B
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
WINA
HRMY
Price
$426.96
$39.60
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$51.33
AVG Volume (30 Days)
84.2K
780.1K
Earning Date
10-15-2025
11-04-2025
Dividend Yield
2.66%
N/A
EPS Growth
2.56
50.44
EPS
11.21
3.17
Revenue
$84,517,400.00
$825,944,000.00
Revenue This Year
$7.05
$20.68
Revenue Next Year
$3.60
$15.93
P/E Ratio
$38.01
$12.57
Revenue Growth
3.35
21.13
52 Week Low
$295.79
$25.52
52 Week High
$527.37
$40.93

Technical Indicators

Market Signals
Indicator
WINA
HRMY
Relative Strength Index (RSI) 51.25 84.53
Support Level $405.86 $32.77
Resistance Level $432.21 $36.20
Average True Range (ATR) 15.68 1.21
MACD 2.91 0.36
Stochastic Oscillator 68.18 96.26

Price Performance

Historical Comparison
WINA
HRMY

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: